SurfSubQ - A Prospective Longitudinal Multicenter Observational Study to Investigate Neurofilament Light Chain Levels and Patient Satisfaction After Subcutaneous Ocrelizumab Administration in Persons With Multiple Sclerosis
SurfSubQ - A Prospective Longitudinal Multicenter Observational Study to Investigate Neurofilament Light Chain Levels and Patient Satisfaction After Subcutaneous Ocrelizumab Administration in Persons With Multiple Sclerosis
The main purpose of the study is to evaluate participant satisfaction after administration of ocrelizumab subcutaneously (SC) after 12 months using the therapy administration satisfaction questionnaire subcutaneous (TASQ-SC).
Inclusion Criteria:
Exclusion Criteria:
global-roche-genentech-trials@gene.com888-662-6728 (U.S. Only)
Aschaffenburg, 63739, Germany
Berlin, 10713, Germany
Chemnitz, 09117, Germany
Cologne, 50935, Germany
Dortmund, 44137, Germany
Eltville, 65343, Germany
Erbach/Odenwald, 64711, Germany
Frankfurt, 60528, Germany
Freiburg im Breisgau, 79106, Germany
Neuruppin, 16816, Germany
Pforzheim, 75172, Germany
Steglitz, 12163, Germany
Stuttgart, 70174, Germany